Wow. Andrew Karaba giving a plenary session talk at AmericanTransplantCongress Infectious Diseases Community of Practice - AST RSV vaccine immunogenicity in SOTr

📢Trainee poster! ID fellow Dr. Lucy Li from Johns Hopkins Division of Infectious Diseases presenting on Time-Varying Impact of Post-Transplant Invasive Fungal Infections on Kidney Allograft Outcomes at #ATC2024Philly Infectious Diseases Community of Practice - AST American Society of Transplantation (AST) Andrew Karaba Olivia Kates, MD Shmuel Shoham @jobadd Nate Permpalung Robin Avery MD

Congrats The Transplant Research Center crew, thank you participants! XBB neutralization wanes 3 mo post bivalent 💉in #transplant recipients, improves w/ 2nd 💉, varies greatly by hx infxn. Many infxn-naive recipients did not mount XBB neut post 2 💉. Important to optimize and tailor💉 schedule

Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients ✅ Just Accepted bit.ly/3XVRsiu

Introducing the 2024 Pilot Research Awardees! 🤩 Huge congrats to Patricia Bloom, MD. Learn more about AASLD Foundation's 2024 awardees at aasldfoundation.org/2024-research-…

🫡

🚨 CRITICAL READ 🚨 If you do research in Transplant ID, this paper is a MUST read. From @CMDurandMD and the The Transplant Research Center a brilliant blueprint in how to build a successful transplant research center. From TransplantID Journal onlinelibrary.wiley.com/doi/10.1111/ti…

Study in NEJM (bit.ly/3YuHjcs) led by Johns Hopkins Medicine provides strong evidence that #HIV-to-HIV transplants are as safe & effective as transplants using organs from donors w/o HIV. See bit.ly/40304Vt. @HopkinsTRC Hopkins Surgery Johns Hopkins Division of Infectious Diseases #ChristineDurandMD

New #LetsTalkID episode out now! Medical editors of the Real-Time Learning Network (Mati Hlatshwayo Davis, MD, MPH, FIDSA, Payal K. Patel, Maria Sundaram, PhD, William Werbel MD PhD) recount their experiences building the project and discuss lessons learned for the future. Transcript: bit.ly/4fu1rRV

Ringing in 2025 with our work evaluating antibody response to RSV vaccines in immunocompromised persons in JAMA (Editor's choice!). A preliminary product of our ongoing EPOC study (emergingpathogens.jhmi.edu) jamanetwork.com/journals/jama/… The Transplant Research Center Andrew Karaba Dorry Segev

1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers. I have never felt so intimidated by my peers The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.

Sanjat Kanjilal of Harvard Medical School joins JAMA Associate Editor Yulin Hswen to discuss the use of machine learning algorithms to assess the management of urinary tract infection and more. ja.ma/42W4Q8I

A bill to dissolve NIAID has been introduced in Congress. Start contacting your US legislators now! congress.gov/bill/119th-con…

Very proud of the 17 dismissed ACIP members for writing this together – Advisory Committee on Immunization Practices at a Crossroads | JAMA | JAMA Network jamanetwork.com/journals/jama/…

#GileadNews: The FDA has approved our injectable HIV-1 prevention medication, making it the first and only twice-yearly #HIV prevention option in the U.S. This approval is helping to usher in the future of prevention as we work to help end the epidemic. gilead.inc/4e9KI6B